The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …

The COVID-19 pandemic has caused havoc all around the world. The causative agent of
COVID-19 is the novel form of the coronavirus (CoV) named SARS-CoV-2, which results in …

To elicit optimal immune responses, messenger RNA vaccines require intracellular delivery
of the mRNA and the careful use of adjuvants. Here we report a multiply adjuvanted mRNA …

Introduction The novel coronavirus infectious disease 2019 (COVID‐19) which is caused by
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged as a gigantic …

The immune response elicited by the current COVID-19 vaccinations declines with time,
especially among the immunocompromised population. Furthermore, the emergence of …

This study characterizes antibody and T-cell immune responses over time until the booster
dose of COronaVIrus Disease 2019 (COVID-19) vaccines in patients with multiple sclerosis …

Post-COVID syndrome develops in 10–20% of people who have recovered from COVID-19
and it is characterized by impaired function of the nervous, cardiovascular, and immune …

Our previous study has found that monoclonal antibodies targeting a conserved epitope
peptide spanning from residues 1144 to 1156 of SARS-CoV-2 spike (S) protein, namely S …

Abstract The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has highlighted the pivotal role of the immune …

Gold nanoparticles (AuNPs) decorated with antigens have recently emerged as promising
tools for vaccine development due to their innate ability to provide stability to antigens and …